Internet medical product promotions will be examined by WHO ad hoc group.
WHO INTERNET PROMOTIONS AD HOC WORKING GROUP will consist of representatives from drug regulatory and enforcement agencies, consumer groups, professional associations, the pharmaceutical industry and "experts in ethics, legal matters, marketing and communication," a World Health Organization resolution adopted May 12 by the World Health Assembly in Geneva states. The working group is charged with reviewing issues in the promotion of medical products on the Internet and formulating recommendations for action.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth